[Candida albicans prosthetic valve endocarditis. Two cases]

Ann Med Interne (Paris). 2002 May;153(3):211-3.
[Article in French]

Abstract

TWO CASES: Candida albicans prosthetic valve endocarditis (PVE) is a rare entity with serious complications. We report two cases of Candida albicans PVE, confirmed by culture of the prosthetic valve. The first patient died twenty days after surgery with cerebral bleeding secondary to multiple mycotic aneurysms, the second patient was still alive eight months following a Saint-Jude aortic valve replacement and prolonged antifungal therapy. The difficulty of diagnosis and management are discussed.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Candida albicans / isolation & purification
  • Candidiasis* / diagnosis
  • Candidiasis* / drug therapy
  • Drug Therapy, Combination
  • Endocarditis / diagnosis
  • Endocarditis / drug therapy
  • Endocarditis / microbiology*
  • Fatal Outcome
  • Female
  • Flucytosine / therapeutic use
  • Heart Valve Prosthesis Implantation
  • Humans
  • Male
  • Middle Aged
  • Prosthesis-Related Infections / diagnosis
  • Prosthesis-Related Infections / drug therapy
  • Prosthesis-Related Infections / microbiology*

Substances

  • Antifungal Agents
  • Amphotericin B
  • Flucytosine